Infrastructure Boom: Railway Stocks Surge After Major Order Wins While Pharma and Tech Face Institutional Pressure

Infrastructure Boom: Railway Stocks Surge After Major Order Wins While Pharma and Tech Face Institutional Pressure​

The market remains keenly focused on industrial growth catalysts, with infrastructure stocks receiving significant boosts following major contract announcements. Alongside sectoral advancements in pharmaceuticals, institutional investors continued their activities across various sectors, participating heavily in block deals and stake sales. Investors are closely watching how these corporate developments translate into sustained stock performance.

Railway Infrastructure Secures Massive Order Wins​

Rail Vikas Nigam (RVNL) announced a substantial business win after receiving a Letter of Acceptance from East Coast Railway. The order involves the construction of bridges on an EPC mode for the 3rd and 4th railway lines between Nergundi to Barang and Khurda Road to Vizianagaram on the Bhadrak to Vizianagaram section. This massive contract is valued at Rs 967.92 crore.

Complementing this development, HFCL secured a significant contract from RVNL worth Rs 2,666.09 crore. This deal covers the BharatNet Phase-III project in Uttar Pradesh. The scope of work includes supplying telecom equipment and related accessories, developing an optical fiber cable network, and managing project maintenance for ten years.

Pharma Giants Achieve US FDA Approval Amid Stake Sales​

Global pharmaceutical major Lupin announced a key international milestone with the approval from the US FDA for its Abbreviated New Drug Application. This approval is for Azilsartan Medoxomil Tablets (40mg and 80mg) in the United States.

The product is bioequivalent to Edarbi of Azurity Pharmaceuticals, Inc., and is designated for treating hypertension in adults to lower blood pressure. Lupin holds a strong position, being the first-to-file for this product and eligible for an 180-day generic drug exclusivity period.

Institutional Trades Dominate Sectoral Activity​

Block deals were observed across multiple sectors, indicating significant institutional movement. Sepia Investments, an affiliate of ChrysCapital, sold 43.28 lakh shares (7.07 percent stake) in Corona Remedies for Rs 748.9 crore. Anchor Partners also offloaded 1.61 lakh shares (0.26 percent stake) in the company for Rs 28 crore, with both deals executed at a price of Rs 1,730 per share.

In institutional movements involving DOMS Industries, FILA, the foreign promoter, sold a 7 percent equity stake (42.48 lakh shares) for Rs 934.7 crore. Axis Mutual Fund and SBI Mutual Fund participated in these transactions, acquiring additional stakes totaling nearly one crore shares worth over Rs 360 crore at an acquisition price of Rs 2,200 per share.

Key Corporate Shifts and Executive Appointments​

Balkrishna Industries saw a key leadership change announced by the board. Saroj Kumar Khuntia was appointed as the Chief Financial Officer (CFO) effective June 18. This appointment follows Madhusudan Bajaj ceasing his duties as CFO and Key Managerial Personnel upon reaching the age of superannuation.

In corporate actions, promoter Bosch Global Software Technologies will sell up to a 7.97 percent stake in Bosch Home Comfort through an offer-for-sale (OFS) scheduled for June 18-19. The floor price for the offering has been fixed at Rs 1,150 per share and includes a greenshoe option of 0.75 percent.

Significant Investor Exits and New Listings Announced​

HDFC Life Insurance Company began reducing its investment in Finolex Industries, the PVC pipes manufacturer. The company sold 80.47 lakh shares (a 1.29 percent stake) across two transactions totaling Rs 136.54 crore. HDFC Life previously held a 1.3 percent stake as of March 2026.

Garg Brothers also offloaded a portion of its holdings in Baazar Style Retail, selling 8.75 lakh shares (a 1.14 percent stake) for Rs 28.76 crore. These corporate movements underscore the ongoing nature of institutional portfolio adjustments across mid-cap stocks.

SME Listings and Future Focus Areas​

The market movement also included several companies trading outside of dividend cycles, providing a snapshot into specific listing dynamics. Stocks trading Ex-Dividend or Ex-Date for Rights included HDB Financial Services, Tata Technologies, JSW Infrastructure, Capital Small Finance Bank, eMudhra, GHCL, Monika Alcobev, Swastika Investmart, and Vimta Labs.

Stocks undergoing SME listings were also reported, including Susan Electricals India, along with specific announcements regarding stock in F&O Ban and Kaynes Technology India.